FDA AnnouncesAIRegulatory Intentions, Following EUAIAct - The National Law Review
FDA must comply with the Office of Management and Budget (OMB)'s March 28 Memorandum on Advancing Governance, Innovation, and Risk Management for …
Read the original at The National Law Review ↗
- Topics
- HealthcareRegulation & PolicyGovernance & Risk Management
- Mentions
- FDA
- Tags
- AI Use Case
- Tracked via
- Google Alert “AI Risks”